APOE and dementia: In addition, the increased catabolism of ω-3s can help explain why APOE4 carriers with dementia are refractory to ω-3 supplementation [29, 30] and potentially, suggest that if there is a role for ω-3 supplements, it is in the prevention of this disease rather than treatment.